drugset / Trial / NCT01284647

A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis

NCT01284647

Phase 4 Completed 156 enrolled Changhai Hospital Eisai China Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of teprenone on chronic non-atrophic erosive gastritis and its therapeutic mechanism

Timeline

Start
2011-02
Primary completion
2012-10
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sucralfate Unknown 4 unknown
Subject Teprenone Unknown 50 mg